“Analysis: Few Surprises with New MS Drugs”

Two Mount Sinai Research Papers Present Evidence of Distinct Molecular Differences Between Brain Tissue from Living People and Tissue Collected After Death

BDSRA Foundation Announces Mount Sinai Health System as New Site in Clinical Centers of Excellence Program

Mount Sinai Receives $3 Million Gift to Help Children With Spinal Cord Injuries and Cerebral Palsy Regain Mobility

Mount Sinai Is First in the Nation to Perform Deep Brain Stimulation Implant as Part of Clinical Trial for Depression

Dysregulation of the Brain’s Reward Learning System Is Identified by Scientists as a Potential Driver and Treatment Target for Cocaine Addiction

Decoding Depression: Researchers Identify Crucial Biomarker That Tracks Recovery From Treatment-Resistant Depression

Mount Sinai Health System to Lead Discussions on Women’s Health, New Paths to Treat and Prevent Brain Disease, and Closing the Health Disparity Gap at the 2023 Aspen Ideas: Health and Aspen Ideas Festival

Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in Children

Cocaine Use Disorder Alters Gene Networks of Neuroinflammation and Neurotransmission in Humans

Mount Sinai Launches Neurometabolomics and Neuroinformatics Core to Combat Rare Brain Diseases

Researchers Identify the Role of an Alzheimer’s Disease Risk Gene in the Brain